MENU
+Compare
XXII
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$5.33
Change
+$0.97 (+22.20%)
Capitalization
2.95M

XXII 22nd Century Group Inc Forecast, Technical & Fundamental Analysis

a plant biotechnology company

Industry Tobacco
XXII
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for XXII with price predictions
Dec 17, 2024

XXII's RSI Oscillator sits in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XXII advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

XXII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 03, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on XXII as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XXII turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XXII declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XXII entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.850) is normal, around the industry mean (3.905). XXII has a moderately low P/E Ratio (0.006) as compared to the industry average of (12.891). XXII's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.928). XXII has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.058). P/S Ratio (0.009) is also within normal values, averaging (1.814).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. XXII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XXII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.

View a ticker or compare two or three
XXII
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XXII is expected to report earnings to fall 11.37% to -7 cents per share on August 08

22nd Century Group Inc XXII Stock Earnings Reports
Q2'23
Est.
$-0.07
Q1'23
Missed
by $0.01
Q4'22
Missed
by $0.06
Q3'22
Est.
$-0.06
Q2'22
Missed
by $0.01
The last earnings report on May 09 showed earnings per share of -7 cents, missing the estimate of -7 cents. With 331.72K shares outstanding, the current market capitalization sits at 2.95M.
A.I. Advisor
published General Information

General Information

a plant biotechnology company

Industry Tobacco

Profile
Fundamentals
Details
Industry
Miscellaneous
Address
321 Farmington Road
Phone
+1 716 270-1523
Employees
64
Web
https://www.xxiicentury.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TIVC0.230.01
+3.77%
Tivic Health Systems
CRMD8.540.23
+2.77%
CorMedix
HGBL1.750.03
+1.74%
Heritage Global
PLMR111.15-1.02
-0.91%
Palomar Holdings
CHRW108.88-1.23
-1.12%
C.H. Robinson Worldwide

XXII and Stocks

Correlation & Price change

A.I.dvisor tells us that XXII and UVV have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XXII and UVV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XXII
1D Price
Change %
XXII100%
-22.00%
UVV - XXII
16%
Poorly correlated
-1.61%
RLX - XXII
10%
Poorly correlated
N/A
KAVL - XXII
6%
Poorly correlated
-1.06%
TPB - XXII
5%
Poorly correlated
-0.30%
PM - XXII
5%
Poorly correlated
+0.08%
More